Sr One Capital Management

Latest statistics and disclosures from Sr One Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACLX, SPRY, DSGN, MLYS, NKTX, and represent 100.00% of Sr One Capital Management's stock portfolio.
  • Reduced shares in these 2 stocks: ACLX (-$44M), EFTR.
  • Sold out of its position in EFTR.
  • Sr One Capital Management was a net seller of stock by $-48M.
  • Sr One Capital Management has $238M in assets under management (AUM), dropping by 22.06%.
  • Central Index Key (CIK): 0001910264

Tip: Access up to 7 years of quarterly data

Positions held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Sr One Capital Management

Sr One Capital Management holds 5 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcellx Common Stock (ACLX) 73.3 $175M -20% 3.1M 55.50
 View chart
Silverback Therapeutics (SPRY) 9.2 $22M 4.0M 5.48
 View chart
Design Therapeutics (DSGN) 7.3 $17M 6.5M 2.65
 View chart
Mineralys Therapeutics (MLYS) 6.5 $15M 1.8M 8.60
 View chart
Nkarta (NKTX) 3.7 $8.8M 1.3M 6.60
 View chart

Past Filings by Sr One Capital Management

SEC 13F filings are viewable for Sr One Capital Management going back to 2021